EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre

Bernadetta Bielecka iD, Iwona Gorczyca-Głowacka iD, Agnieszka Ciba-Stemplewska iD, Beata Wożakowska-Kapłon

International Journal of Environmental Research and Public Health · 2023

DOI: 10.3390/ijerph20126145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Bernadetta Bielecka und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1st Clinic of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Centre, 25-736 Kielce, Poland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Percutaneous Coronary Intervention, Stroke, Thromboembolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is associated with an increased risk of stroke. Therefore, patients with AF require appropriate management and anticoagulant therapy. To balance therapy risks and benefits, oral anticoagulants (OAC) treatment should be ‘tailored’ in patients at a high risk of stroke and bleeding. However, some studies have demonstrated that certain groups of patients do not receive anticoagulants despite the high risk of stroke or thromboembolism. The study aimed to analyse therapeutic methods of stroke prevention in very high-risk patients (CHA2DS2-VASc score of ≥5 in men and ≥6 in women), identify factors predisposing against the use of OACs and assess the administration of anticoagulants before the introduction of non-vitamin K antagonist OAC (NOAC) in 2004–2011 and beyond (years 2012–2019). The analysis covered 2441 patients with AF at a very high thromboembolic risk who were hospitalised in a reference cardiological centre from 2004 to 2019. Data concerning patients’ sex, age, comorbidities, type of AF, renal and echocardiographic parameters, reasons for hospitalisation and applied treatment were collected from medical records. HAS-BLED, CHADS2, and CHA2DS2-VASc scores were calculated for all patients. The treatment with oral anticoagulants was compared in the entire population over 2004–2011 and 2012–2019. In this study, a fifth of patients were not treated with OAC. Most patients hospitalised in the years 2012–2019 were treated with OAC. The predictors of not using OAC turned out to be: age of >74 years, heart failure, cancer, paroxysmal AF, and acute coronary syndrome (ACS) or elective coronary angiography/percutaneous coronary intervention (PCI) as a reason for hospitalisation. The introduction of NOAC was associated with a decline in the use of VKA (from 62% to 19.1%) and APT (from 29.1% to 1.3%). This study outlines reasons to initiate OAC treatment in very high-risk patients in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPercutaneous Coronary InterventionStrokeThromboembolismMaleHumansFemaleAgedAnticoagulantsPolandHemorrhageAdministration, OralRisk Factors

Stichwörter der Autor:innen

atrial fibrillationnon-vitamin K antagonist oral anticoagulantsoral anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • 1st Clinic of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Centre, 25-736 Kielce, Poland.
  • Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland.
  • Clinic of Internal Medicine, 25-736 Kielce, Poland.

ORCID-Profile: Bernadetta Bielecka, Iwona Gorczyca-Głowacka, Agnieszka Ciba-Stemplewska

Zitieren

APA

Bielecka, B., Gorczyca-Głowacka, I., Ciba-Stemplewska, A., & Wożakowska-Kapłon, B. (2023). Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20126145

Vancouver

Bielecka B, Gorczyca-Głowacka I, Ciba-Stemplewska A, Wożakowska-Kapłon B. Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20126145

BibTeX
@article{Bielecka2023,
  author = {Bielecka, Bernadetta and Gorczyca-Głowacka, Iwona and Ciba-Stemplewska, Agnieszka and Wożakowska-Kapłon, Beata},
  title = {Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2023},
  doi = {10.3390/ijerph20126145}
}
Kostenlos starten →